首页 › 白血病 › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 白血病临床试验
12项针对 白血病的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
招募中观察性研究
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
招募中早期 I 期
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Philadelphia
其他城市的 白血病试验
- Houston, TX28 项研究
- Boston, MA25 项研究
- New York City, NY19 项研究
- Los Angeles, CA16 项研究
- Chicago, IL16 项研究
- Durham, NC13 项研究
- Columbus, OH12 项研究
- Baldwin Park, CA12 项研究
- Nashville, TN12 项研究
- Seattle, WA11 项研究
- Milwaukee, WI11 项研究
- Birmingham, AL10 项研究
Philadelphia的其他研究
- 癌症（所有类型）60 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 前列腺癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。